logo

For the Inventor, By the Inventor

Stenløse, Denmark

Daniel Rodriguez Greve

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Stenlose, DK (2006 - 2012)
  • Stenløse, DK (2009 - 2017)
  • Ballerup, DK (2016 - 2024)

Company Filing History:

goldMedal6 out of 506 
 
H. Lundbeck A/s
 patents
silverMedal5 out of 67 
 
Leo-pharma A/s
 patents
bronzeMedal3 out of 22 
 
Union Therapeutics A/s
 patents

Years Active: 2006-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11981681 - Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors (2024-05-14),
2. 11384096 - Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors (2022-07-12),
3. 11292799 - Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors (2022-04-05),
4. 10851116 - Bicyclic amines as novel JAK kinase inhibitors (2020-12-01),
5. 10799507 - 5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid derivatives as novel JAK kinase inhibitors (2020-10-13),
6. 9586961 - Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof (2017-03-07),
7. 9346809 - Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors (2016-05-24),
8. 9233964 - Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use therof (2016-01-12),
9. 8299071 - Substituted pyridine derivatives (2012-10-30),
10. 7812020 - Substituted pyridine derivatives (2010-10-12),
11. 7683058 - Substituted pyrimidine derivatives (2010-03-23),
12. 7612068 - Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives (2009-11-03),
13. 7601870 - Substituted aniline derivatives (2009-10-13),
14. 7067501 - Aryloxyphenyl and arylsulfanylphenyl derivatives (2006-06-27),

Title: The Innovative Contributions of Daniel Rodriguez Greve

Introduction

Daniel Rodriguez Greve is a notable inventor based in Stenløse, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on phosphodiesterase inhibitors. With a total of 14 patents to his name, his inventions have the potential to impact therapeutic practices significantly.

Latest Patents

Among his latest patents is the invention of substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors. This invention relates to novel compounds that exhibit phosphodiesterase inhibitory activity, which can be utilized in various therapeutic applications. The pharmaceutical compositions derived from these compounds are designed to treat diseases effectively.

Career Highlights

Throughout his career, Daniel has worked with prominent companies in the pharmaceutical industry, including H. Lundbeck A/S and Leo Pharma A/S. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Daniel has collaborated with several professionals in his field, including Nikolay Khanzhin and Mario Rottländer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of new inventions.

Conclusion

Daniel Rodriguez Greve's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to pave the way for advancements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…